|
|
|
Volumn , Issue 82, 2006, Pages 1-4
|
|
Recombinant activated factor VII for bleeding in patients without inherited bleeding disorders.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BLOOD CLOTTING FACTOR 7A;
HEMOSTATIC AGENT;
RECOMBINANT PROTEIN;
ARTICLE;
BLEEDING;
BRAIN HEMORRHAGE;
CANADA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG APPROVAL;
ECONOMICS;
HEMOPHILIA A;
HUMAN;
INJURY;
INTRAOPERATIVE PERIOD;
MORTALITY;
PHASE 3 CLINICAL TRIAL;
PRACTICE GUIDELINE;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
UNITED STATES;
CANADA;
CEREBRAL HEMORRHAGE;
CLINICAL TRIALS, PHASE III;
DRUG APPROVAL;
FACTOR VIIA;
HEMOPHILIA A;
HEMORRHAGE;
HEMOSTATICS;
HUMANS;
INTRAOPERATIVE PERIOD;
PRACTICE GUIDELINES;
RANDOMIZED CONTROLLED TRIALS;
RECOMBINANT PROTEINS;
TREATMENT OUTCOME;
UNITED STATES;
WOUNDS AND INJURIES;
|
|
EID: 33645729859
PISSN: 14886324
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
